Approval · Notice of Compliance 34874 · 2025
ANTHRASIL: Notice of Compliance 34874
Issued February 17, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34874
- Date
- February 17, 2025
- Company
- Emergent Biosolutions Canada IncWinnipeg, Manitoba, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change to the drug product manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANTHRASIL | Not yet assigned | — |
Medicinal ingredients
- ANTHRAX IMMUNOGLOBULIN (HUMAN) 60 UNIT per VIAL